Citigroup Inc. Analysts Give Sanofi SA (SAN) a €88.00 Price Target
Sanofi SA (EPA:SAN) has been assigned a €88.00 ($103.53) price target by equities researchers at Citigroup Inc. in a research report issued on Friday. The brokerage presently has a “neutral” rating on the stock.
A number of other research analysts also recently commented on SAN. UBS AG set a €82.00 ($96.47) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Wednesday, June 14th. Morgan Stanley set a €92.00 ($108.24) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Friday. Goldman Sachs Group, Inc. (The) set a €82.00 ($96.47) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Tuesday, August 1st. Kepler Capital Markets set a €90.00 ($105.88) price target on Sanofi SA and gave the stock a “buy” rating in a research report on Thursday, September 7th. Finally, Berenberg Bank set a €97.00 ($114.12) price target on Sanofi SA and gave the stock a “neutral” rating in a research report on Monday, July 31st. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €87.88 ($103.39).
Sanofi SA (EPA:SAN) traded up 0.68% on Friday, hitting €86.26. 1,735,066 shares of the stock traded hands. Sanofi SA has a 52 week low of €24.55 and a 52 week high of €86.26. The stock has a 50 day moving average of €26.12 and a 200 day moving average of €26.01. The firm has a market capitalization of €108.32 billion and a PE ratio of 12.03.
COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/10/06/citigroup-inc-analysts-give-sanofi-sa-san-a-88-00-price-target.html.
About Sanofi SA
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.